Response to immune checkpoint inhibitor (ICI) rechallenge in patients with metastatic renal cell carcinoma who progressed on prior ICI: A systematic review and meta-analysis. Biomarkers of response to ...

Please provide your email address to receive an email when new articles are posted on . An investigational anti-MAdCAM antibody was safe, well tolerated and superior to placebo for inducing remission ...

U.S. FDA Grants Shire Orphan Drug Designation for Investigational Anti-MAdCAM Antibody SHP647 for the Treatment of Moderately to Severely Active Ulcerative Colitis in Pediatric Patients Cambridge, Ma.

Correlation between CARINH expression and clinical outcomes in metastatic clear-cell renal cell carcinoma (mccRCC). Association of KIM-1–MAdCAM-1 composite score quartiles with progression-free and ...